Department of Veterans Affairs and Insurance Coverage and Processing

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Department of Veterans Affairs

Insurance Coverage and Processing

Health insurer Excellus will not fund Alzheimer’s drug Aduhelm

pharmaphorum

AUGUST 12, 2021

Health insurer Excellus BlueCross BlueShield has said it will not cover treatment with Biogen and Eisai’s new Alzheimer’s disease drug Aduhelm because it has not been shown to be medically effective. The post Health insurer Excellus will not fund Alzheimer’s drug Aduhelm appeared first on.

Insurance Coverage and Processing

Insurance Coverage and Processing Department of Veterans Affairs

Disease of the Month: Age-Related Macular Degeneration (AMD)

PharmaShots

FEBRUARY 9, 2023

It includes various tests such as, visual acuity test (for clarity), visual field test (for peripheral vision), tonometry test (pressure in eyes), pupil response test (way of lights enter into eyes) Optical Coherence Tomography: A non-invasive retina imaging test that uses light waves to take high resolution cross-section pictures of retina.

Insurance Coverage and Processing

Insurance Coverage and Processing Department of Veterans Affairs

Pharmacist Digest

Health insurer Excellus will not fund Alzheimer’s drug Aduhelm

Disease of the Month: Age-Related Macular Degeneration (AMD)

Stay Connected